Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Gains from Investment Securities: 2009-2011

Historic Gains from Investment Securities for Lexicon Pharmaceuticals (LXRX) over the last 1 years, with Sep 2011 value amounting to $79,000.

  • Lexicon Pharmaceuticals' Gains from Investment Securities rose 227.42% to $79,000 in Q3 2011 from the same period last year, while for Sep 2011 it was $32,000, marking a year-over-year change of. This contributed to the annual value of -$812,000 for FY2024, which is 46.30% up from last year.
  • According to the latest figures from Q3 2011, Lexicon Pharmaceuticals' Gains from Investment Securities is $79,000, which was up 71.74% from $46,000 recorded in Q2 2011.
  • Lexicon Pharmaceuticals' 5-year Gains from Investment Securities high stood at $79,000 for Q3 2011, and its period low was -$62,000 during Q3 2010.
  • Over the past 3 years, Lexicon Pharmaceuticals' median Gains from Investment Securities value was $2,000 (recorded in 2009), while the average stood at $6,800.
  • Data for Lexicon Pharmaceuticals' Gains from Investment Securities shows a peak YoY spiked of 227.42% (in 2011) over the last 5 years.
  • Over the past 3 years, Lexicon Pharmaceuticals' Gains from Investment Securities (Quarterly) stood at $2,000 in 2009, then reached -$62,000 in 2010, then soared by 227.42% to $79,000 in 2011.
  • Its Gains from Investment Securities stands at $79,000 for Q3 2011, versus $46,000 for Q2 2011 and -$31,000 for Q1 2011.